Magnetic Localization of Breast Lesions: A Large-Scale European Evaluation in a National Cancer Institute.


Journal

Clinical breast cancer
ISSN: 1938-0666
Titre abrégé: Clin Breast Cancer
Pays: United States
ID NLM: 100898731

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 19 07 2023
revised: 16 08 2023
accepted: 17 08 2023
medline: 27 11 2023
pubmed: 14 9 2023
entrez: 13 9 2023
Statut: ppublish

Résumé

For decades the standard for preoperative breast lesions' localization has been wire localization. In recent years the options for nonwired localization have significantly expanded and include radioactive seeds, radar reflectors, radiofrequency identification tags and magnetic seeds. The aim of our study is to evaluate on a large scale the performance of preoperative magnetic seed localization of nonpalpable breast lesions. We prospectively collected data on all patients undergoing image-guided magnetic seed localization from September 2019 to December 2022. We analyzed imaging findings, histological results, and type of surgery. The primary outcome was the successful localization rate. Secondary outcomes were the successful placement rate, the ease of percutaneous positioning, the procedural complications, and the reintervention rate. A total of 1123 magnetic seeds were placed in 1084 patients by 4 radiologists under ultrasound (1053) or stereotactic (70) guidance. All seeds were detectable transcutaneously in all breasts sizes and at all depths by 7 surgeons with a success rate of 100%. A total of 97.5% seeds were correctly placed into the target lesions (only 2.5% were dislocated). All radiologists have shown good compliance during the procedure, and there were no complications or safety issues. The reoperation rate was 5.1%. Image-guided localization with magnetic seeds is an easy, safe, reliable, and effective method for localizing nonpalpable breast lesions. Both radiologists and surgeons agreed that the technology was intuitive to use and that it can be widely applied in preoperative localization in breast units.

Identifiants

pubmed: 37704563
pii: S1526-8209(23)00211-2
doi: 10.1016/j.clbc.2023.08.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e491-e498

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors have no relevant financial or nonfinancial competing interests to report.

Auteurs

Catherine Depretto (C)

Breast Imaging Unit, Radiology Department, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Gianmarco Della Pepa (G)

Postgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy.

Claudia De Berardinis (C)

Postgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy. Electronic address: claudia.deberardinis@unimi.it.

Laura Suman (L)

Breast Imaging Unit, Radiology Department, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Claudio Ferranti (C)

Breast Imaging Unit, Radiology Department, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Monica Marchesini (M)

Breast Imaging Unit, Radiology Department, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Ilaria Maugeri (I)

Breast Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Gabriele Martelli (G)

Breast Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Massimiliano Gennaro (M)

Breast Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Secondo Folli (S)

Breast Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Giancarlo Pruneri (G)

Pathology Department, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Gianfranco Paride Scaperrotta (GP)

Breast Imaging Unit, Radiology Department, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH